NUZ 6.25% 22.5¢ neurizon therapeutics limited

Ann: First Patient of Cohort 2 Dosed in MND Trial, page-60

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 8,942 Posts.
    lightbulb Created with Sketch. 1729
    If Roger hadn't said he couldn't wait to get back to Australia then it wouldn't be an issue for me but he has stated it on more than one occasion.
    It goes to credibility on doing what you say you are going to do.

    With not one timeline having been meet, discussions which go nowhere, progress that at best is as slow as a snail.
    In companies like PAA shareholders expectations are based on what companies announce, what management say.
    They need to be careful on how things are reported, wording etc but PAA have been wrong so many times.
    it's the same around the mnd patient screening, they stated 4 patients being screened then only one being dozed then I would expect some explanation around the other 3
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.